BBusiness Read More Trump, Eli Lilly, Novo Nordisk unveil deals to cut obesity drug pricesNovember 6, 2025 U.S. President Donald Trump attends an event to make an announcement from the Oval Office at the White…
HHealth care Read More Metsera calls Novo Nordisk’s new bid superior to Pfizer offerNovember 4, 2025 The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
BBusiness Read More Pfizer (PFE) earnings Q3 2025November 4, 2025 Smith Collection | Archive Photos | Getty Images Pfizer on Thursday reported third-quarter earnings and revenue that topped…
HHealth care Read More Pfizer files second lawsuit against Novo Nordisk, MetseraNovember 4, 2025 A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…
HHealth care Read More Pfizer sues Metsera, Novo Nordisk over rival obesity drug bidNovember 1, 2025 Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer said on Friday it had filed a lawsuit against Metsera and Novo…
HHealth care Read More We’re raising our Eli Lilly price target — what a difference a quarter makesOctober 31, 2025 Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its…
BBusiness Read More Eli Lilly (LLY) earnings Q3 2025October 30, 2025 A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
MMedication Read More Eli Lilly Novo Nordisk stock fall on Trump GLP-1 price commentsOctober 24, 2025 Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to…
HHealth care Read More A key step forward for Novo Nordisk’s GLP-1 pillOctober 22, 2025 Novo Nordisk flags flutter outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025.…
BBusiness Read More Stock market today: Live updatesOctober 17, 2025 Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October…